首页> 外文OA文献 >Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC)

【2h】

Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC)

机译：重组人精氨酸酶的聚乙二醇化衍生物（rhArg1）在癌症治疗中具有持续的体内活性：体内，体外和体外对肝癌的药效学的制备，表征和分析以及对肝细胞癌的作用单元格（HCC）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Wheatley Denys N; Cheng Paul; Arnold Simon; Kwok Sui-Yi; So Pui-Kin; Chong Hiu-Chi; Lam Tin-Lun; Lam Wai-Man; Tsui Sam-Mui; Lo Wai-Hung; Leung Yun-Chung;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma [J] . Yau Thomas, Cheng Paul N., Chan Pierre, Investigational new drugs. . 2015,第2期

机译：聚乙二醇化重组人精氨酸酶1在晚期肝细胞癌中的初步疗效，安全性，药代动力学，药效学和生活质量研究
2. Dendritic cells transfected with hepatocellular carcinoma (HCC) total RNA induce specific immune responses against HCC in vitro and in vivo [J] . XieB.H., YangJ.Y., LiH.P., Clinical & translational oncology : . 2014,第8期

机译：转染肝细胞癌（HCC）总RNA的树突状细胞在体内和体外诱导针对HCC的特异性免疫反应
3. ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo [J] . Christian Moser, Sven A Lang, Akira Mori, BMC Cancer . 2008,第1期

机译：ENMD-1198，一种新型微管蛋白结合剂，可降低人肝细胞癌（HCC）细胞中的HIF-1alpha和STAT3活性，并在体内抑制其生长和血管生成
4. Non-invasive liver cancer ablation using histotripsy in an in vivo murine hepatocellular carcinoma (HCC) model [C] . Tejaswi Worlikar, Eli Vlaisavljevich, Tyler Gerhardson, IEEE International Ultrasonics Symposium . 2017

机译：在体内小鼠肝细胞癌（HCC）模型中使用组织曲霉进行无创肝癌消融
5. The anti-cancer activities of Paeoniae Radix extracts on human hepatocellular carcinoma cell-line HepG2 and multidrug resistant human hepatocellular carcinoma cell-line R-HepG2 and their action mechanisms. [D] . Li, Lok Yee Mandy. 2004

机译：e药提取物对人肝癌细胞HepG2和多药耐药人肝癌细胞R-HepG2的抗癌活性及其作用机制。
6. Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC) [O] . Sam-Mui Tsui, Wai-Man Lam, Tin-Lun Lam, 2009

机译：重组人精氨酸酶的聚乙二醇化衍生物（rhArg1）在癌症治疗中具有持续的体内活性：体内体外药效学的制备表征和分析以及对肝细胞癌细胞（HCC）的作用
7. Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy : preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC) [O] . Tsui, SM, Lam, WM, Lam, TL, 2009

机译：重组人精氨酸酶的聚乙二醇化衍生物（rhArg1）在癌症治疗中具有持续的体内活性：体内，体外药效学的制备，表征和分析以及对肝细胞癌细胞（HCC）的作用

Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC)

著录项

引文网络

相似文献

相关主题

期刊订阅